Perrigo Set Up Israeli Co. To Skip Tax, US Says In $163M Row
Perrigo created an Israeli subsidiary in 2006 as an "empty box," and the assignment of a heartburn drug contract to the subsidiary should be disregarded in a $163 million tax dispute,...To view the full article, register now.
Already a subscriber? Click here to view full article